Difficult cases in fertility preservation

Precongress Course 5

SIG Fertility Preservation   Special Interest Groups Fertility Preservation

Course type

Course Co-ordinators

Kirsten Tryde Macklon (Denmark), Richard Anderson (United Kingdom), Michael von Wolff (Switzerland), Michael Grynberg (France), Aude Braye (Belgium), Stine Gry Kristensen (Denmark)

Course description 
Throughout Europe and the rest of the world fertility preservation is offered to more and more patients faced with a potential loss of fertility. But although results are increasingly good, there remain a group of patients for whom fertility preservation is a challenge due to either the nature of their disease or medical conditions in the individual patient. In this program we will concentrate on some of these problems and through case presentations and discussions hopefully be able to offer solutions on how best to help our patients in the future.


Expected educational outcomes

After this course the participants will have learned about some of the challenges we face when working with fertility preservation. They will be able to better help those patients whose disease or medical condition could pose a challenge to their wish for fertility preservation. Patients that we normally find it difficult to help.


Target audience 

Clinicians, nurses and counsellors involved in fertility preservation services



Monday 28 June 2021

Session 1: The patient with leukaemia
Chair invited, but not yet confirmed
09:00 - 09:30
The patient who already had chemo.
Dror Meirow, Israel
09:30 - 09:45
09:45 - 10:15
The patient at risk of recurrence.
Stine Gry Kristensen, Denmark
10:15 - 10:30
10:30 - 11:00
Coffee break
Session 2: The patient with ovarian disease
Chair invited, but not yet confirmed
11:00 - 11:30
Bilateral endometrioma.
Michael von Wolff, Switzerland
11:30 - 11:45
11:45 - 12:15
Ovarian cancer or Borderline ovarian cysts.
Catherine Uzan, France
12:15 - 12:30
12:30 - 13:30
Lunch break
Session 3: The male who cannot produce a sperm sample
Chair invited, but not yet confirmed
13:30 - 14:00
Inability to ejaculate.
Herman Tournaye, Belgium
14:00 - 14:15
14:15 - 14:45
The transgender woman.
Richard Anderson, United Kingdom
14:45 - 15:00
15:00 - 15:30
Coffee break
Session 4: The patient with an expected adverse outcome of ovarian stimulation
Chair invited, but not yet confirmed
15:30 - 16:00
Low ovarian reserve or unexpected poor outcome.
Michaƫl Grynberg, France
16:00 - 16:15
16:15 - 16:45
Risk of thrombosis vs. risk of bleeding.
Speaker invited, but not confirmed
16:45 - 17:00